Pfizer announces data for XELJANZ® (tofacitinib citrate) in rheumatoid arthritis
25 September 2013 | By Pfizer
Long-term safety and efficacy data of XELJANZ up to five years will be presented at the American College Of Rheumatology 2013 annual meeting...